AnxA1 expression is associated with progression of inflammation in both IBD models and in patients, and previous findings from our group evidenced AnxA1 plays a role on PPARγ activation and actions (da Rocha et al., 2019). Here, ANXA1 is linked to inflammatory bowel disease.